Delivery of therapeutic doses of doxorubicin to the mouse lung using lung-accumulating liposomes proves unsuccessful

[1]  C. Hunt,et al.  Liposome disposition in vivo. VI: Delivery to the lung. , 1984, Journal of pharmaceutical sciences.

[2]  F. Szoka,et al.  The use of a new radioactive-iodine labeled lipid marker to follow in vivo disposition of liposomes: comparison with an encapsulated aqueous space marker. , 1982, Research communications in chemical pathology and pharmacology.

[3]  C. Bucana,et al.  Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. , 1982, Cancer research.

[4]  F. Szoka,et al.  Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes. , 1982, European journal of cancer & clinical oncology.

[5]  C. Hunt,et al.  Liposome disposition in vivo. III. Dose and vesicle-size effects. , 1981, Biochimica et biophysica acta.

[6]  S. Shinozawa,et al.  Tissue distribution and antitumor effect of liposome-entrapped doxorubicin (adriamycin) in Ehrlich solid tumor-bearing mouse. , 1981, Acta medica Okayama.

[7]  Z. Tökés,et al.  In vitro and in vivo studies with adriamycin liposomes. , 1979, Biochemical and biophysical research communications.

[8]  K. Fu,et al.  Interaction of radiation and adriamycin on the EMT6 tumor as a function of tumor size and assay method. , 1979, International journal of radiation oncology, biology, physics.

[9]  C. Hunt,et al.  Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size. , 1979, Drug metabolism and disposition: the biological fate of chemicals.

[10]  S. Carter.  Adriamycin-a review. , 1975, Journal of the National Cancer Institute.

[11]  A. Moore,et al.  Tissue distribution and disposition of daunomycin (NCS-82151) in mice: fluorometric and isotopic methods. , 1970, Cancer chemotherapy reports.

[12]  E. Acton,et al.  Tissue distribution of doxorubicin and doxorubicinol in rats receiving multiple doses of doxorubicin , 2004, Cancer Chemotherapy and Pharmacology.

[13]  M. Mareel,et al.  Biology of cancer invasion and metastasis. , 1992, Acta oto-rhino-laryngologica Belgica.